Limin Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Limin Zhao has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
Xin Shao
School of Physics Science and Information Technology, Liaocheng University, Liaocheng 252000, China
9 shared publicationsHui Zhao
School of Materials Science and Engineering, Liaocheng University
8 shared publicationsBo Ge
School of Materials Science and Engineering, Liaocheng University
7 shared publicationsWenzhi Li
School of Materials Science and Engineering, Liaocheng University, Liaocheng 252059, P. R. China
7 shared publicationsXue Feng
General Institute of Non-Ferrous Metals
7 shared publications- Bo Ge
School of Materials Science and Engineering, Liaocheng University, Liaocheng, China
6 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (41) , 48801-48809
Co 2 P@CoPi@NC with engineered heterointerfaces and carbon networks for hydrazine-assisted water splitting
Co 2 P@CoPi@NC hybrids with well-defined heterointerfaces and carbon networks are fabricated through metal phosphonate pyrolysis. The catalyst achieves superior HzOR activity, enabling hydrogen production for hydrazine-assisted water splitting.
- 16 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (41) , 48801-48809
Open AccessCo 2 P@CoPi@NC with engineered heterointerfaces and carbon networks for hydrazine-assisted water splitting
Co 2 P@CoPi@NC hybrids with well-defined heterointerfaces and carbon networks are fabricated through metal phosphonate pyrolysis. The catalyst achieves superior HzOR activity, enabling hydrogen production for hydrazine-assisted water splitting.
- 18 February 2026
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 42 (8) , 6333-6343
Boosting Photocatalytic H 2 O 2 Production via the Synergy of Protonation and Heterojunction in Covalent Organic Frameworks
With high specific surface area, tunable framework structures, and outstanding chemical stability, covalent organic frameworks (COFs) can serve as photocatalysts to convert water into H2O2 under light irradiation. However, their low electronic transfer rates and narrow optical response range significantly constrain the application of COFs in photocatalysis research. Herein, a compound with an S-scheme heterojunction structure was synthesized by combining Dma-TAPT COFs with polyaniline (PANI) via a solvothermal method. Furthermore, protonated COFs were used to broaden the light absorption range and enhance charge transport. Owing to the synergistic effect, the photocatalytic H2O2 production of PANI-Dma-TAPT after protonation increased by 2.58 times (relative to Dma-TAPT). Under acidic conditions (pH 1), the H2O2 yield of H-PANI-Dma-TAPT reached 1171.7 μmol·g-1, which was 3.7 times higher than that of Dma-TAPT. This study offers both practical insights and theoretical understanding into photocatalytic H2O2 production.
- 18 February 2026
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 42 (8) , 6333-6343
Boosting Photocatalytic H 2 O 2 Production via the Synergy of Protonation and Heterojunction in Covalent Organic Frameworks
With high specific surface area, tunable framework structures, and outstanding chemical stability, covalent organic frameworks (COFs) can serve as photocatalysts to convert water into H2O2 under light irradiation. However, their low electronic transfer rates and narrow optical response range significantly constrain the application of COFs in photocatalysis research. Herein, a compound with an S-scheme heterojunction structure was synthesized by combining Dma-TAPT COFs with polyaniline (PANI) via a solvothermal method. Furthermore, protonated COFs were used to broaden the light absorption range and enhance charge transport. Owing to the synergistic effect, the photocatalytic H2O2 production of PANI-Dma-TAPT after protonation increased by 2.58 times (relative to Dma-TAPT). Under acidic conditions (pH 1), the H2O2 yield of H-PANI-Dma-TAPT reached 1171.7 μmol·g-1, which was 3.7 times higher than that of Dma-TAPT. This study offers both practical insights and theoretical understanding into photocatalytic H2O2 production.
- 19 December 2024
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 329, 125620
Designing fluorescent covalent organic frameworks through regulation of link bond for selective detection of Al3+ and Ce3+
- 19 December 2024
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 329, 125620
Designing fluorescent covalent organic frameworks through regulation of link bond for selective detection of Al3+ and Ce3+
- Open Access
- 2 November 2023
- Published by BMJ
- Vol. 11 (Suppl 1) , A1287
1168 Identification of fully human TCR-mimic antibodies targeting the KRAS G12V/HLA complex generated in HLA-transgenic RenMabTM mice
Background Mutations in the small GTPase protein KRAS drive several cancers, owing to accelerated growth and differentiation phenotypes resulting from altered GDP-GTP exchange and GTP hydrolysis rates. As targeting RAS proteins with traditional drug modalities has proved to be challenging, new therapeutic strategies are needed. Here, we generated and screened TCR-mimic antibody hits targeting the mutant KRAS G12V peptide/HLA complex, as the majority of KRAS mutations occur at this residue.1 Methods HLA-transgenic RenMice™ were immunized with KRAS G12V/HLA-A0301 or KRAS G12V/HLA-A1101 peptide-MHC (pMHC) complexes. The specificity of antibody hits recovered from the mice, as well as a positive control antibody previously described,2 was tested on HLA-A overexpressing cells in the context of various KRAS peptides by flow cytometry. Positive hits were assessed for heavy and light chain germline gene usage and CDR3 length, and KD values were measured. To assess specificity of the antibodies, binding of two candidate antibody hits to other peptide and/or HLA complexes were tested. Alanine scanning substitutions of the KRAS G12V peptide were also performed to identify the residues critical for TCR-mimic antibody recognition. Killing of HLA-A0301+ cells with KRAS G12V or wildtype KRAS by TCR-mimic antibody candidate 2 conjugated to a CD3-targeting antibody was subsequently measured (by LDH activity) in the context of human T cells. Results We identified TCR-mimic antibodies with specificity for KRAS G12V residues 7–16 complexed with HLA-A0301 or HLA-A1101 by flow cytometry. KRAS G12V/HLA-A1101 and KRAS G12V/HLA-A0301 antibody hits exhibited varying degrees of germline gene diversity and CDR3 length, with the majority of KRAS G12V/HLA-A0301 antibodies exhibiting higher affinity than the positive control. KRAS G12V/HLA-A0301 antibodies specifically bound HLA-A0301 overexpressing cells pulsed with KRAS G12V decamer peptide in a dose-dependent manner, but did not bind KRAS G12C, G12D, WT peptide or unpulsed controls. Furthermore, KRAS G12V/HLA-A0301 antibodies did not bind HLA-A1101 overexpressing cells loaded with KRAS mutant or WT peptides, or HLA-A0301 overexpressing cells loaded with off-target peptide. Alanine substitutions revealed that residue V6 of KRAS G12V was required for antibody binding. Cytotoxicity assays demonstrate specificity of KRAS G12V/HLA-A0301 antibody for KRAS G12V+/HLA-A0301+ cells. Conclusions Using our novel fully human HLA-transgenic RenMice, we have successfully generated and screened TCR-mimic antibodies specific for KRAS G12V/HLA-A0301 pMHC or KRAS G12V/HLA-A1101 pMHC complexes for further preclinical investigation. References Moore AR, Rosenberg SC, McCormick F, et al. RAS-targeted therapies: is the undruggable drugged?. Nat Rev Drug Discov 2020;19:902. https://doi.org/10.1038/s41573–020-0089–1 Douglass J, Hsiue EH, Mog BJ, Hwang MS, DiNapoli SR, Pearlman AH, Miller MS, Wright KM, Azurmendi PA, Wang Q, Paul S, Schaefer A, Skora AD, Molin MD, Konig MF, Liu Q, Watson E, Li Y, Murphy MB, Pardoll DM, Bettegowda C, Papadopoulos N, Gabelli SB, Kinzler KW, Vogelstein B, Zhou S. Bispecific antibodies targeting mutant RAS neoantigens. Sci Immunol. 2021 Mar 1;6(57):eabd5515. doi: 10.1126/sciimmunol.abd5515. PMID: 33649101; PMCID: PMC8141259. Ethics Approval All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Biocytogen Beijing Co., Ltd.
- 2 November 2023
- Published by BMJ
- Vol. 11 (Suppl 1) , A1287
Open Access1168 Identification of fully human TCR-mimic antibodies targeting the KRAS G12V/HLA complex generated in HLA-transgenic RenMabTM mice
Background Mutations in the small GTPase protein KRAS drive several cancers, owing to accelerated growth and differentiation phenotypes resulting from altered GDP-GTP exchange and GTP hydrolysis rates. As targeting RAS proteins with traditional drug modalities has proved to be challenging, new therapeutic strategies are needed. Here, we generated and screened TCR-mimic antibody hits targeting the mutant KRAS G12V peptide/HLA complex, as the majority of KRAS mutations occur at this residue.1 Methods HLA-transgenic RenMice™ were immunized with KRAS G12V/HLA-A0301 or KRAS G12V/HLA-A1101 peptide-MHC (pMHC) complexes. The specificity of antibody hits recovered from the mice, as well as a positive control antibody previously described,2 was tested on HLA-A overexpressing cells in the context of various KRAS peptides by flow cytometry. Positive hits were assessed for heavy and light chain germline gene usage and CDR3 length, and KD values were measured. To assess specificity of the antibodies, binding of two candidate antibody hits to other peptide and/or HLA complexes were tested. Alanine scanning substitutions of the KRAS G12V peptide were also performed to identify the residues critical for TCR-mimic antibody recognition. Killing of HLA-A0301+ cells with KRAS G12V or wildtype KRAS by TCR-mimic antibody candidate 2 conjugated to a CD3-targeting antibody was subsequently measured (by LDH activity) in the context of human T cells. Results We identified TCR-mimic antibodies with specificity for KRAS G12V residues 7–16 complexed with HLA-A0301 or HLA-A1101 by flow cytometry. KRAS G12V/HLA-A1101 and KRAS G12V/HLA-A0301 antibody hits exhibited varying degrees of germline gene diversity and CDR3 length, with the majority of KRAS G12V/HLA-A0301 antibodies exhibiting higher affinity than the positive control. KRAS G12V/HLA-A0301 antibodies specifically bound HLA-A0301 overexpressing cells pulsed with KRAS G12V decamer peptide in a dose-dependent manner, but did not bind KRAS G12C, G12D, WT peptide or unpulsed controls. Furthermore, KRAS G12V/HLA-A0301 antibodies did not bind HLA-A1101 overexpressing cells loaded with KRAS mutant or WT peptides, or HLA-A0301 overexpressing cells loaded with off-target peptide. Alanine substitutions revealed that residue V6 of KRAS G12V was required for antibody binding. Cytotoxicity assays demonstrate specificity of KRAS G12V/HLA-A0301 antibody for KRAS G12V+/HLA-A0301+ cells. Conclusions Using our novel fully human HLA-transgenic RenMice, we have successfully generated and screened TCR-mimic antibodies specific for KRAS G12V/HLA-A0301 pMHC or KRAS G12V/HLA-A1101 pMHC complexes for further preclinical investigation. References Moore AR, Rosenberg SC, McCormick F, et al. RAS-targeted therapies: is the undruggable drugged?. Nat Rev Drug Discov 2020;19:902. https://doi.org/10.1038/s41573–020-0089–1 Douglass J, Hsiue EH, Mog BJ, Hwang MS, DiNapoli SR, Pearlman AH, Miller MS, Wright KM, Azurmendi PA, Wang Q, Paul S, Schaefer A, Skora AD, Molin MD, Konig MF, Liu Q, Watson E, Li Y, Murphy MB, Pardoll DM, Bettegowda C, Papadopoulos N, Gabelli SB, Kinzler KW, Vogelstein B, Zhou S. Bispecific antibodies targeting mutant RAS neoantigens. Sci Immunol. 2021 Mar 1;6(57):eabd5515. doi: 10.1126/sciimmunol.abd5515. PMID: 33649101; PMCID: PMC8141259. Ethics Approval All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Biocytogen Beijing Co., Ltd.
- 15 August 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (31)
Construction of Triphenylamine‐based Two‐dimensional Covalent Organic Frameworks for High‐performance Capacitive Energy Storage and Exploration of Redox Units
Covalent organic frameworks (COFs) have received more interest as energy storage devices for their unique topological structure and excellent electrochemical performance. However, the confirmation of active center and the mechanism of charge storage in COFs supercapacitors is still a significant challenge. Here, a series of Tp‐based COFs with different link units have been obtained through Schiff base reaction. All the synthesized COFs exhibited high crystallinity and excellent thermal stability. Based on similar structure, electrochemical analysis and DFT calculation was used to identify the redox active sites. Because of their conjugated structures containing redox‐active triphenylamine groups, the obtained a‐COFs exhibited specific capacitance of 115 F ⋅ g −1 in 1 M H 2 SO 4 at 0.1 A ⋅ g −1 and retained 70 % capacitive after 1000 cycles. Our findings provide a new routine for designing new COFs electrode materials.
- 15 August 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (31)
Construction of Triphenylamine‐based Two‐dimensional Covalent Organic Frameworks for High‐performance Capacitive Energy Storage and Exploration of Redox Units
Covalent organic frameworks (COFs) have received more interest as energy storage devices for their unique topological structure and excellent electrochemical performance. However, the confirmation of active center and the mechanism of charge storage in COFs supercapacitors is still a significant challenge. Here, a series of Tp‐based COFs with different link units have been obtained through Schiff base reaction. All the synthesized COFs exhibited high crystallinity and excellent thermal stability. Based on similar structure, electrochemical analysis and DFT calculation was used to identify the redox active sites. Because of their conjugated structures containing redox‐active triphenylamine groups, the obtained a‐COFs exhibited specific capacitance of 115 F ⋅ g −1 in 1 M H 2 SO 4 at 0.1 A ⋅ g −1 and retained 70 % capacitive after 1000 cycles. Our findings provide a new routine for designing new COFs electrode materials.
- 8 November 2022
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 25 (5) , 3766-3771
Hierarchical manganese valence gradient MnO 2 via phosphorus doping for cathode materials with improved stability
The oxygen defects concentration in P-MnO x increased and formed a gradient valence structure, which could result in the narrowing of band gap and improve the electrochemical performance of samples for supercapacitor and aqueous ZIBs.
- 8 November 2022
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 25 (5) , 3766-3771
Hierarchical manganese valence gradient MnO 2 via phosphorus doping for cathode materials with improved stability
The oxygen defects concentration in P-MnO x increased and formed a gradient valence structure, which could result in the narrowing of band gap and improve the electrochemical performance of samples for supercapacitor and aqueous ZIBs.
- 25 August 2022
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 51 (37) , 14352-14358
A double responsive fluorescent platform for sensing heavy metal ions based on a dual-emitting fluorescent covalent organic framework hydrogel film
A new luminescent hybrid material with dual-emission centers (Eu@Dye@TpDq hydrogel) based on a covalent organic framework (COF) has been successfully prepared. First, we designed a dye (coumarin) modified COF (TpDq) hybrid fluorescent material (Dye@TpDq), and then the material was formed into a hydrogel film, with an Eu3+ ion being introduced as another luminescent center into the material during the cross-linking process. As a dual-emission fluorescent platform, it exhibits a double-response towards different heavy metal ions: a ratiometric identification response to Cu(II), and a turn-off fluorescence response to Cr(VI). This research not only introduces a novel synthesis of Eu3+-functionalized double emitting COF-based hydrogels, but also inspires the development of COF-based multifunctional analytical tools.
- 25 August 2022
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 51 (37) , 14352-14358
A double responsive fluorescent platform for sensing heavy metal ions based on a dual-emitting fluorescent covalent organic framework hydrogel film
A new luminescent hybrid material with dual-emission centers (Eu@Dye@TpDq hydrogel) based on a covalent organic framework (COF) has been successfully prepared. First, we designed a dye (coumarin) modified COF (TpDq) hybrid fluorescent material (Dye@TpDq), and then the material was formed into a hydrogel film, with an Eu3+ ion being introduced as another luminescent center into the material during the cross-linking process. As a dual-emission fluorescent platform, it exhibits a double-response towards different heavy metal ions: a ratiometric identification response to Cu(II), and a turn-off fluorescence response to Cr(VI). This research not only introduces a novel synthesis of Eu3+-functionalized double emitting COF-based hydrogels, but also inspires the development of COF-based multifunctional analytical tools.